Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-04 Option Award |
2024-01-08 4:39 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
136,500 | $0 | 366,500 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-31 5:10 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
24,500 | $0 | 230,000 (Direct) |
View |
| 2023-04-17 Option Award |
2023-04-20 06:00 am |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
97,500 | $0 | 205,500 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 8:00 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
39,000 | $0 | 108,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:32 pm |
N/A 2032-01-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
51,000 | $0 | 101,000 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-02 4:48 pm |
N/A 2031-09-01 |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
50,000 | $0 | 100,000 (Direct) |
View |